Expertise in
3
conditions

Nicole S. Bodmer

Zurich, ZH, CH 
Expertise in
3
conditions
Zurich, ZH, CH 

Overview

Nicole Bodmer practices practicing medicine in Zurich, Switzerland.

Ms. Bodmer is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Infantile Neutropenia, Agranulocytosis, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Zurich, ZH, Switzerland
Other Locations
Bern, BE, Switzerland
Zug, ZG, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2026
Intervention Type: Drug, Procedure, Other, Biological
Study Drugs: Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Dexrazoxane Hydrochloride, Doxorubicin, Etoposide, Filgrastim, Ifosfamide, Imatinib Mesylate, Leucovorin Calcium, Mercaptopurine, Methotrexate, Methylprednisolone, Pegaspargase, Prednisolone, Hydrocortisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3

37 Total Publications

Efficacy and Safety Evidence Supporting Cancer Drug Approvals in Switzerland (2001-2020): A Meta-Analysis of Pivotal Randomised Controlled Trials.
Efficacy and Safety Evidence Supporting Cancer Drug Approvals in Switzerland (2001-2020): A Meta-Analysis of Pivotal Randomised Controlled Trials.
Journal: The Lancet regional health. Europe
Published: January 23, 2026

Frequently Asked Questions about Nicole S. Bodmer

Is Nicole S. Bodmer a top-rated expert for Infantile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Nicole S. Bodmer is classified as an Advanced expert for Infantile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nicole S. Bodmer participate in research or clinical trials?

Yes. Nicole S. Bodmer has published 37 articles and abstracts on conditions like Infantile Neutropenia. You can view a list of Nicole S. Bodmer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bodmer's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile